Chronic Lymphocytic Leukemia During COVID: A Patient Story
Please see Full Prescribing Information for CALQUENCE® (acalabrutinib): https://bit.ly/3Ly3ru0
Learn more about chronic lymphocytic leukemia (CLL) and treatment with CALQUENCE from Dan, a patient with CLL, and Mark, a physician’s assistant.
Select Safety Information CALQUENCE is a prescription oral treatment for adults with chronic lymphocytic leukemia or small lymphocytic lymphoma. May cause serious side effects including: serious infections, bleeding problems, decrease in blood cell count, new cancers, and heart rhythm problems. Some may lead to death. Tell your doctor if you experience infections such as flu-like symptoms; unexpected bleeding such as blood in your stool or urine; or heart rhythm problems such as fast or irregular heartbeat. Use sun protection when outside.
Chapters: 0:00 - Intro
0:44 – Welcome and Panelist Introductions
4:20 – A CLL Diagnosis Story
12:30 – Managing Stress and Staying Positive
17:52 – COVID-19 Vaccine Considerations in CLL
24:15 – Living with CLL During COVID-19 Pandemic
30:47 – Key Points about CLL and the Role of Genetic Testing
34:37 – Navigating CLL Treatment Options
35:45 – BTKi Therapy and a Patient Experience’s with CALQUENCE
40:00 Factors to Consider for Starting and Continuing CLL Treatment
52:09 – Patient Tips for Taking Their CLL Medications
55:22 – Managing Side Effects
1:01:23 – Support Groups and Resources
1:03:10 – CALQUENCE Important Safety Information
-
Category
No comments found